Clinical Trial Update: The Optimal Sequential Therapy After Long Term Denosumab Treatment [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial completed evaluating the optimal sequential therapy after long-term denosumab treatment for osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Prolia (denosumab)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Osteoporosis | Phase 4 | Status: COMPLETED